|
|
Cosmo Pharmaceuticals N.V.
VIE •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeVIE
Market Capitalization1,464.67 mln
Float8.69 mln
Earnings Date07/23/2026
Key Fundamentals
EPS-0.22
ROE-0.75
RPS6.52
ROIC-1.49
ROA-0.58
EBITDA, mln11.96
EV / EBITDA112
EV / EBIT-1,678
Revenue, mln104
EV / Revenue12.86
Financial Strength
Altman Z-Score8.17
Piotroski F-Score
2
/ 9
Beneish M-Score-4.54
Price to Intrinsic Value2.02
Shiller PE Ratio232
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-4.91% |
11
/ 100
 |
| 1 Month |
-7.81% |
12
/ 100
|
| 2 Months |
-37.6% |
2
/ 100
 |
| 6 Months |
-33.19% |
5
/ 100
 |
| 1 Year |
19.84% |
61
/ 100
 |
|
| |
